You are here
- Home
- Therapy Areas
- Oncology/Infection
A Phase II, Double-Blind, Randomised, Placebo-Controlled Study to Assess the Efficacy of AZD6244 (Hyd-Sulfate) in Combination with Docetaxel, Compared with Docetaxel Alone, in 2nd Line Patients with KRAS Mutation Positive Locally Advanced Metastatic Non Small Cell Lung Cancer (Stage IIIB- IV)
- Disease
- solid tumour
- Drug Name
- AZD6244
- Generic Name
- AZD6244
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- II
- Start Date
- Apr 20, 2009
- Study Name
- D1532C00016
- Study Id
- D1532C00016
- ClinicalTrials.gov ID
- NCT00890825
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
